Antagonist Anti-Cd40 Monoclonal Antibody, Chir-12.12, Inhibits Growth Of A Rituximab-Resistant Nhl Xenograft Model And Achieves Synergistic Activity When Combined With Ineffective Rituximab

BLOOD(2004)

引用 2|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要